Filing Details
- Accession Number:
- 0001179110-13-004098
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-03-05 10:03:14
- Reporting Period:
- 2013-03-01
- Filing Date:
- 2013-03-05
- Accepted Time:
- 2013-03-05 10:03:14
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1145460 | Alere Inc. | ALR | In Vitro & In Vivo Diagnostic Substances (2835) | 043565120 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1272540 | Hilde Eylenbosch | 51 Sawyer Road, Suite 200 Waltham 02453 | President, Alere International | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2013-03-01 | 2,500 | $16.20 | 32,636 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2013-03-01 | 2,391 | $22.69 | 30,245 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Shares | Employee Stock Option (Right to Buy) | Disposition | 2013-03-01 | 2,500 | $0.00 | 2,500 | $16.20 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2004-03-10 | 2013-03-10 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 43,143 | Indirect | Spouse |
| Common Stock | 3,248 | Direct |
Footnotes
- Reresents sell to cover exercise of expiring stock options.
- The sales reported on this Form 4 were effected purusant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2012.
- The price represents the average purchase price for 14 separate transactions reported on this line. The price of the transactions reported on this line range from $22.68 to $22.70. The reporting person hereby undertakes to provide upon request to the SEC,the issuer or any stockholder of the issuer the full informaiton regarding the number of shares and prices at which the transaction was effected.
- This reporting person disclaims beneficial ownership of the reported securities.
- These securities are jointly owned with the reporting person's spouse.
- This derivative security does not have a price.
Billionaire Hedge Funds
